Literature DB >> 18222094

Identification of clusters from reactions of ruthenium arene anticancer complex with glutathione using nanoscale liquid chromatography Fourier transform ion cyclotron mass spectrometry combined with (18)O-labeling.

Fuyi Wang1, Stefan Weidt, Jingjing Xu, C Logan Mackay, Pat R R Langridge-Smith, Peter J Sadler.   

Abstract

Reactions of the anticancer complex [(eta(6)-bip)Ru(en)Cl](+) (where bip is biphenyl and en is ethylenediamine) with the tripeptide glutathione (gamma-L-Glu-L-Cys-Gly; GSH), the abundant intracellular thiol, in aqueous solution give rise to two ruthenium cluster complexes, which could not be identified by electrospray mass spectrometry (ESI-MS) using a quadrupole mass analyzer. Here we use Fourier transform ion cyclotron mass spectrometry (nanoLC-FT-ICR MS) to identify the clusters separated by nanoscale liquid chromatography as the tetranuclear complex [{(eta(6)-bip)Ru(GSO(2))}(4)](2-) (2) and dinuclear complex [{(eta(6)-bip)Ru(GSO(2))(2)}(2)](8-) (3) containing glutathione sulfinate (GSO(2)) ligands. Use of (18)OH(2) showed that oxygen from water can readily be incorporated into the oxidized glutathione ligands. These data illustrate the power of high-resolution MS for identifying highly charged multinuclear complexes and elucidating novel reaction pathways for metallodrugs, including ligand-based redox reactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18222094     DOI: 10.1016/j.jasms.2007.12.002

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  15 in total

1.  Applications of laser desorption and electrospray ionization mass spectrometry at the transition between clusters and colloids.

Authors:  P J Dyson; B F Johnson; J S McIndoe; P R Langridge-Smith
Journal:  Inorg Chem       Date:  2000-06-12       Impact factor: 5.165

2.  A strategy for generating naked-metal clusters for gas-phase reactivity studies by FTICR-MS.

Authors:  Colin P G Butcher; Adriana Dinca; Paul J Dyson; Brian F G Johnson; Patrick R R Langridge-Smith; J Scott McIndoe
Journal:  Angew Chem Int Ed Engl       Date:  2003-12-01       Impact factor: 15.336

3.  Unequivocal determination of metal atom oxidation state in naked heme proteins: Fe(III)myoglobin, Fe(III)cytochrome c, Fe(III)cytochrome b5, and Fe(III)cytochrome b5 L47R.

Authors:  F He; C L Hendrickson; A G Marshall
Journal:  J Am Soc Mass Spectrom       Date:  2000-02       Impact factor: 3.109

4.  Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide.

Authors:  Fuyi Wang; Juraj Bella; John A Parkinson; Peter J Sadler
Journal:  J Biol Inorg Chem       Date:  2005-02-26       Impact factor: 3.358

5.  How does single oxygen atom addition affect the properties of an Fe-nitrile hydratase analogue? The compensatory role of the unmodified thiolate.

Authors:  Priscilla Lugo-Mas; Abhishek Dey; Liang Xu; Steven D Davin; Jason Benedict; Werner Kaminsky; Keith O Hodgson; Britt Hedman; Edward I Solomon; Julie A Kovacs
Journal:  J Am Chem Soc       Date:  2006-08-30       Impact factor: 15.419

6.  Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate.

Authors:  Fuyi Wang; Jingjing Xu; Abraha Habtemariam; Juraj Bella; Peter J Sadler
Journal:  J Am Chem Soc       Date:  2005-12-21       Impact factor: 15.419

7.  Inhibition of cancer cell growth by ruthenium(II) arene complexes.

Authors:  R E Morris; R E Aird; P del S Murdoch; H Chen; J Cummings; N D Hughes; S Parsons; A Parkin; G Boyd; D I Jodrell; P J Sadler
Journal:  J Med Chem       Date:  2001-10-25       Impact factor: 7.446

8.  A novel inhibitor for Fe-type nitrile hydratase: 2-cyano-2-propyl hydroperoxide.

Authors:  Masanari Tsujimura; Masafumi Odaka; Hiroshi Nakayama; Naoshi Dohmae; Hiroyuki Koshino; Tadao Asami; Mikio Hoshino; Koji Takio; Shigeo Yoshida; Mizuo Maeda; Isao Endo
Journal:  J Am Chem Soc       Date:  2003-09-24       Impact factor: 15.419

9.  Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.

Authors:  Fuyi Wang; Haimei Chen; Simon Parsons; Iain D H Oswald; James E Davidson; Peter J Sadler
Journal:  Chemistry       Date:  2003-12-05       Impact factor: 5.236

10.  Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B.

Authors:  Rob L M van Montfort; Miles Congreve; Dominic Tisi; Robin Carr; Harren Jhoti
Journal:  Nature       Date:  2003-06-12       Impact factor: 49.962

View more
  5 in total

1.  Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution.

Authors:  Debbie C Crans; Boyan Zhang; Ernestas Gaidamauskas; Anastasios D Keramidas; Gail R Willsky; Chris R Roberts
Journal:  Inorg Chem       Date:  2010-05-03       Impact factor: 5.165

2.  The interactions of the ruthenium(II)-cymene complexes with lysozyme and cytochrome c.

Authors:  Dragana Stanic-Vucinic; Stefan Nikolic; Katarina Vlajic; Mirjana Radomirovic; Jelena Mihailovic; Tanja Cirkovic Velickovic; Sanja Grguric-Sipka
Journal:  J Biol Inorg Chem       Date:  2020-02-04       Impact factor: 3.358

3.  Competitive binding sites of a ruthenium arene anticancer complex on oligonucleotides studied by mass spectrometry: ladder-sequencing versus top-down.

Authors:  Kui Wu; Wenbing Hu; Qun Luo; Xianchan Li; Shaoxiang Xiong; Peter J Sadler; Fuyi Wang
Journal:  J Am Soc Mass Spectrom       Date:  2013-02-13       Impact factor: 3.109

Review 4.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

5.  Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh2(CH3COO)4 with Cysteine and Its Derivatives.

Authors:  Farideh Jalilehvand; Alejandra Enriquez Garcia; Pantea Niksirat
Journal:  ACS Omega       Date:  2017-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.